Emily R. Cox

2.5k total citations
56 papers, 1.5k citations indexed

About

Emily R. Cox is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Emily R. Cox has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Economics and Econometrics, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Emily R. Cox's work include Pharmaceutical Economics and Policy (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical studies and practices (9 papers). Emily R. Cox is often cited by papers focused on Pharmaceutical Economics and Policy (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical studies and practices (9 papers). Emily R. Cox collaborates with scholars based in Australia, United States and Switzerland. Emily R. Cox's co-authors include Brenda R. Motheral, Rochelle Henderson, Michael A. Fischer, Niteesh K. Choudhry, Jyotsna Mehta, William H. Shrank, Doug Mager, Edeltraut Garbe, Bradley C. Martin and Michael L. Johnson and has published in prestigious journals such as JAMA, PEDIATRICS and Medicine & Science in Sports & Exercise.

In The Last Decade

Emily R. Cox

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily R. Cox Australia 20 610 290 193 190 183 56 1.5k
Karolina Andersson Sundell Sweden 25 632 1.0× 314 1.1× 407 2.1× 300 1.6× 164 0.9× 74 1.7k
Jaana E. Martikainen Finland 19 319 0.5× 273 0.9× 155 0.8× 107 0.6× 81 0.4× 44 1.3k
Anna Birna Almarsdóttir Denmark 19 309 0.5× 331 1.1× 518 2.7× 177 0.9× 262 1.4× 79 1.5k
Alan Lyles United States 22 547 0.9× 164 0.6× 763 4.0× 240 1.3× 320 1.7× 47 1.8k
Gabriel Sanfélix‐Gimeno Spain 24 217 0.4× 127 0.4× 152 0.8× 279 1.5× 146 0.8× 92 1.6k
Saira Jan United States 16 431 0.7× 107 0.4× 198 1.0× 373 2.0× 195 1.1× 27 1.1k
Derjung M. Tarn United States 22 220 0.4× 230 0.8× 369 1.9× 289 1.5× 612 3.3× 73 1.6k
Lise M. Bjerre Canada 19 314 0.5× 110 0.4× 295 1.5× 74 0.4× 297 1.6× 54 1.4k
David P. Nau United States 18 375 0.6× 206 0.7× 508 2.6× 932 4.9× 276 1.5× 49 2.0k
Anita Chawla United States 20 510 0.8× 118 0.4× 66 0.3× 81 0.4× 377 2.1× 47 2.2k

Countries citing papers authored by Emily R. Cox

Since Specialization
Citations

This map shows the geographic impact of Emily R. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily R. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily R. Cox more than expected).

Fields of papers citing papers by Emily R. Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily R. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily R. Cox. The network helps show where Emily R. Cox may publish in the future.

Co-authorship network of co-authors of Emily R. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Emily R. Cox. A scholar is included among the top collaborators of Emily R. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily R. Cox. Emily R. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cox, Emily R., Shelley E. Keating, M. Hordern, et al.. (2024). Effect of low-volume combined aerobic and resistance high-intensity interval training on vascular health in people with type 2 diabetes: a randomised controlled trial. European Journal of Applied Physiology. 124(9). 2819–2833. 3 indexed citations
2.
Jansson, Anna K., David R. Lubans, Mitch J. Duncan, et al.. (2024). Increasing participation in resistance training using outdoor gyms: A study protocol for the ecofit type III hybrid effectiveness implementation trial. Contemporary Clinical Trials Communications. 41. 101358–101358. 1 indexed citations
3.
Freene, Nicole, et al.. (2024). The Physical Activity Advice Continuum—A Guide for Physical Activity Promotion in Health Care. Journal of Physical Activity and Health. 21(4). 311–315. 2 indexed citations
4.
Cox, Emily R., et al.. (2023). Does greater distance from the hospital exacerbate socioeconomic barriers to neonatal intensive care unit clinic attendance?. Journal of Rural Medicine. 18(2). 55–61. 7 indexed citations
5.
Keating, Shelley E., Ilaria Croci, Matthew P. Wallen, et al.. (2023). High-intensity Interval Training for the Management of Nonalcoholic Steatohepatitis: Participant Experiences and Perspectives. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 6 indexed citations
6.
Keating, Shelley E., Ilaria Croci, Matthew P. Wallen, et al.. (2022). High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial. Digestive Diseases and Sciences. 68(5). 2123–2139. 22 indexed citations
7.
Cox, Emily R., et al.. (2019). Embryology, Ovarian Follicle Development. StatPearls. 9 indexed citations
8.
Cox, Emily R., Shelley E. Keating, Jeff S. Coombes, & Nicola W. Burton. (2018). Potential Utility of Self-Report Measures of Affect to Optimise Exercise Adherence in People with Type 2 Diabetes. Current Diabetes Reviews. 15(4). 302–308. 3 indexed citations
9.
Phillips, Cameron, et al.. (2012). Medicines Book for Aboriginal Health Workers.
10.
Sedjo, Rebecca L. & Emily R. Cox. (2009). The Influence of Targeted Education on Medication Persistence and Generic Substitution among Consumer‐Directed Health Care Enrollees. Health Services Research. 44(6). 2079–2092. 14 indexed citations
11.
12.
Shrank, William H., Suzanne M. Cadarette, Emily R. Cox, et al.. (2009). Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization?. Medical Care. 47(3). 319–325. 73 indexed citations
13.
Sedjo, Rebecca L. & Emily R. Cox. (2008). Lowering copayments: impact of simvastatin patent expiration on patient adherence.. PubMed. 14(12). 813–8. 25 indexed citations
14.
Cox, Emily R., Rochelle Henderson, & Brenda R. Motheral. (2004). Health Plan Member Experience With Point-of-Service Prescription Step Therapy. Journal of Managed Care Pharmacy. 10(4). 291–298. 17 indexed citations
15.
Cox, Emily R., et al.. (2001). Medicare Beneficiaries??? Management of Capped Prescription Benefits. Medical Care. 39(3). 296–301. 62 indexed citations
16.
Cox, Emily R., et al.. (2000). Exhaustion of prescription benefits and Medicare beneficiaries' disenrollment from managed care.. JAMA. 284(20). 2596–7. 3 indexed citations
17.
Vogel, Ronald J. & Emily R. Cox. (2000). Analytic dimensions of a prescription-medication benefit in medicare. Clinical Therapeutics. 22(4). 470–493. 1 indexed citations
18.
Hakim, Zafar, et al.. (1999). The Economics of Multiple Sclerosis. PharmacoEconomics. 15(3). 229–240. 36 indexed citations
19.
Kortt, Michael A., Paul C. Langley, & Emily R. Cox. (1998). A review of cost-of-illness studies on obesity. Clinical Therapeutics. 20(4). 772–779. 83 indexed citations
20.
Draugalis, JoLaine R., et al.. (1998). Algorithms for Estimating Learning Opportunity and Productivity Impact at Clerkship Sites. American Journal of Pharmaceutical Education. 62(3). 258–265. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karolina Andersson Sundell Breakdown of academic impact, for papers by Jaana E. Martikainen Breakdown of academic impact, for papers by Anna Birna Almarsdóttir Breakdown of academic impact, for papers by Alan Lyles Breakdown of academic impact, for papers by Gabriel Sanfélix‐Gimeno Breakdown of academic impact, for papers by Saira Jan Breakdown of academic impact, for papers by Derjung M. Tarn Breakdown of academic impact, for papers by Lise M. Bjerre Breakdown of academic impact, for papers by David P. Nau Breakdown of academic impact, for papers by Anita Chawla
Rankless by CCL
2026